Literature DB >> 18321997

Heterogeneity of human macrophages in culture and in atherosclerotic plaques.

Stephen W Waldo1, Yifu Li, Chiara Buono, Bin Zhao, Eric M Billings, Janet Chang, Howard S Kruth.   

Abstract

Research suggests that monocytes differentiate into unique lineage-determined macrophage subpopulations in response to the local cytokine environment. The present study evaluated the atherogenic potential of two divergent lineage-determined human monocyte-derived macrophage subpopulations. Monocytes were differentiated for 7 days in the presence of alternative macrophage development cytokines: granulocyte-macrophage colony-stimulating factor to produce granulocyte-macrophage-CSF macrophages (GM-Mac), or macrophage colony-stimulating factor (M-CSF) to produce M-Mac. Gene chip analyses of three monocyte donors demonstrated differential expression of inflammatory and cholesterol homeostasis genes in the macrophage subpopulations. Quantitative PCR confirmed a fivefold elevation in the expression of genes that promote reverse cholesterol transport (PPAR-gamma, LXR-alpha, and ABCG1) and macrophage emigration from lesions (CCR7) in GM-Mac compared to that in M-Mac. Immunocytochemistry confirmed enhanced expression of the proinflammatory marker CD14 in M-Mac relative to GM-Mac. M-Mac spontaneously accumulated cholesterol when incubated with unmodified low-density lipoprotein whereas GM-Mac only accumulated similar levels of cholesterol after protein kinase C activation. Immunostained human coronary arteries showed that macrophages with similar antigen expression to that of M-Mac (CD68(+)/CD14(+)) were predominant within atherosclerotic lesions whereas macrophages with antigen expression similar to GM-Mac (CD68(+)/CD14(-)) were predominant in areas devoid of disease. The identification of macrophage subpopulations with different gene expression patterns and, thus, different potentials for promoting atherosclerosis has important experimental and clinical implications and could prove to be a valuable finding in developing therapeutic interventions in diseases dependent on macrophage function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321997      PMCID: PMC2276432          DOI: 10.2353/ajpath.2008.070513

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  75 in total

1.  Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein.

Authors:  Howard S Kruth; Nancy L Jones; Wei Huang; Bin Zhao; Itsuko Ishii; Janet Chang; Christian A Combs; Daniela Malide; Wei-Yang Zhang
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

2.  Reproducibility, fidelity, and discriminant validity of mRNA amplification for microarray analysis from primary hematopoietic cells.

Authors:  Liang Li; Joe Roden; Bruce E Shapiro; Barbara J Wold; Smita Bhatia; Stephen J Forman; Ravi Bhatia
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

Review 3.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

4.  Microarray-based comparison of three amplification methods for nanogram amounts of total RNA.

Authors:  Ruchira Singh; Rajanikanth J Maganti; Sairam V Jabba; Martin Wang; Glenn Deng; Joe Don Heath; Nurith Kurn; Philine Wangemann
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-21       Impact factor: 4.249

5.  CCL17 and CCL22 attenuate CCL5-induced mast cell migration.

Authors:  M Juremalm; N Olsson; G Nilsson
Journal:  Clin Exp Allergy       Date:  2005-06       Impact factor: 5.018

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 7.  Insulin-like growth factors and coronary heart disease.

Authors:  Robert C Kaplan; Howard D Strickler; Thomas E Rohan; Radhika Muzumdar; David L Brown
Journal:  Cardiol Rev       Date:  2005 Jan-Feb       Impact factor: 2.644

8.  CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells.

Authors:  A Melián; Y J Geng; G K Sukhova; P Libby; S A Porcelli
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.

Authors:  Shin-ichi Kawachi; Noriyuki Takeda; Akihiko Sasaki; Yoshiaki Kokubo; Kazuhisa Takami; Hiroshi Sarui; Makoto Hayashi; Noriyoshi Yamakita; Keigo Yasuda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-29       Impact factor: 8.311

10.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more
  97 in total

Review 1.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

3.  Modulation of macrophage phenotype by cell shape.

Authors:  Frances Y McWhorter; Tingting Wang; Phoebe Nguyen; Thanh Chung; Wendy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 4.  Atherosclerosis as autoimmune disease.

Authors:  Petr Sima; Luca Vannucci; Vaclav Vetvicka
Journal:  Ann Transl Med       Date:  2018-04

5.  Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.

Authors:  Peiwen Chen; Hao Zuo; Hu Xiong; Matthew J Kolar; Qian Chu; Alan Saghatelian; Daniel J Siegwart; Yihong Wan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

6.  Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.

Authors:  Ramya Ganesan; Karen M Henkels; Lucile E Wrenshall; Yasunori Kanaho; Gilbert Di Paolo; Michael A Frohman; Julian Gomez-Cambronero
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

7.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

Authors:  Joseph J Boyle; Heather A Harrington; Emma Piper; Kay Elderfield; Jaroslav Stark; Robert C Landis; Dorian O Haskard
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

8.  Methionine and methionine sulfoxide treatment induces M1/classical macrophage polarization and modulates oxidative stress and purinergic signaling parameters.

Authors:  Lien M Dos Santos; Tatiane M da Silva; Juliana H Azambuja; Priscila T Ramos; Pathise S Oliveira; Elita F da Silveira; Nathalia S Pedra; Kennia Galdino; Carlus A T do Couto; Mayara S P Soares; Rejane G Tavares; Roselia M Spanevello; Francieli M Stefanello; Elizandra Braganhol
Journal:  Mol Cell Biochem       Date:  2016-10-17       Impact factor: 3.396

9.  Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages.

Authors:  Jason L Johnson; Graciela B Sala-Newby; Yasmin Ismail; Concepción M Aguilera; Andrew C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

10.  TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation.

Authors:  Lei Lei; Ying Xiong; Jia Chen; Jin-Bo Yang; Yi Wang; Xin-Ying Yang; Catherine C Y Chang; Bao-Liang Song; Ta-Yuan Chang; Bo-Liang Li
Journal:  J Lipid Res       Date:  2009-02-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.